As I mentioned before, there are only a few controlled
trials of magnesium supplementation and psychiatric disorders.
Not exact matches
A 2012 meta - analysis
of available literature in the European Journal
of Clinical Nutrition found: «
Magnesium supplementation appears to achieve a small but clinically significant reduction in BP, an effect worthy
of future prospective large randomized
trials using solid methodology.»
One randomized, double - blind, placebo - controlled
trial has shown that oral
magnesium supplementation (30 mmol elemental
magnesium / d) for 6 mo resulted in a significant improvement in endothelium - dependent brachial artery flow — mediated vasodilation in 50 patients with coronary artery disease (21), which indicates a direct effect
of magnesium intake on endothelial function.